收藏切换
Research Progress on Soy Isoflavones in the Regulation of Metabolic Disorders
收藏切换
Guoquan SHAO1, Zhe MING1, Wensheng WANG1, *, Nana ZHANG2, *, Fengzhong WANG2
Science and Technology of Food Industry | 2026, 47(13) : 457 - 467
Less
收藏切换
Science and Technology of Food Industry | 2026, 47(13): 457-467
• Reviews •
Research Progress on Soy Isoflavones in the Regulation of Metabolic Disorders
Full
Guoquan SHAO1, Zhe MING1, Wensheng WANG1, *, Nana ZHANG2, *, Fengzhong WANG2
Affiliations
  • 1College of Life Sciences, Henan Normal University, Xinxiang 453002, China
  • 2Institute of Nuclear Energy Utilization, Chinese Academy of Agricultural Sciences, Beijing 100080, China
Published: 2026-07-01 doi: 10.13386/j.issn1002-0306.2025060037
Outline
收藏切换

Metabolic disorders such as obesity, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD) are becoming increasingly prevalent worldwide. Although various therapeutic strategies exist, limitations in efficacy, tolerability, and long-term compliance remain major challenges. Consequently, natural bioactive compounds with well-defined mechanisms of action and favorable safety profiles have garnered growing research interest. Soy isoflavones, a group of naturally occurring plant-derived ingredients, have attracted considerable attention due to their promising effects in ameliorating metabolic disorders. This review summarizes recent in vitro, animal, and clinical studies on the regulatory effects of soy isoflavones and their major active components on obesity, T2DM, and NAFLD. Soy isoflavones ameliorate insulin resistance and maintain glucose homeostasis by modulating the PI3K/Akt and FOXO1/GSK3β signaling pathways. Furthermore, soy isoflavones regulate lipid metabolism balance by suppressing lipid synthesis and promoting fatty acid oxidation via the AMPK/SREBP-1C and PGC-1α pathways. Soy isoflavones also exhibit protective effects against the development and progression of metabolic disorders through mechanisms including suppression of inflammatory responses, amelioration of oxidative stress, and modulation of gut microbiota and its metabolic products. This review provides a comprehensive overview of the therapeutic potential and underlying mechanisms of soy isoflavones in managing glucose and lipid metabolic disorders, aiming to support further research and the development of soy isoflavones-based functional products.

soy isoflavones  /  metabolic diseases  /  obesity  /  diabetes  /  non-alcoholic fatty liver disease
邵国权, 明哲, 王文晟, 张娜娜, 王凤忠. 大豆异黄酮改善代谢紊乱的研究进展. 食品工业科技, 2026 , 47 (13) : 457 -467 . DOI: 10.13386/j.issn1002-0306.2025060037
Guoquan SHAO, Zhe MING, Wensheng WANG, Nana ZHANG, Fengzhong WANG. Research Progress on Soy Isoflavones in the Regulation of Metabolic Disorders[J]. Science and Technology of Food Industry, 2026 , 47 (13) : 457 -467 . DOI: 10.13386/j.issn1002-0306.2025060037
Year 2026 volume 47 Issue 13
142
69
Cite this Article
BibTeX
Article Info
doi: 10.13386/j.issn1002-0306.2025060037
  • Receive Date:2025-06-05
  • Online Date:2026-10-24
  • Published:2026-07-01
Article Data
Affiliations
History
  • Received:2025-06-05
Affiliations
    1College of Life Sciences, Henan Normal University, Xinxiang 453002, China
    2Institute of Nuclear Energy Utilization, Chinese Academy of Agricultural Sciences, Beijing 100080, China
References
Share
https://castjournals.cast.org.cn/joweb/spgykj/EN/10.13386/j.issn1002-0306.2025060037
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT